Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesion Performance of Esflurbiprofen Topical System in Healthy Subjects
NCT07307794Phase 1Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of esflurbiprofen in pain, sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoint: Characterization of the patch adhesion. Started Jan 2026; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT07307794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07307794.